Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

(MedPage Today) -- In cystic fibrosis, vanzacaftor-tezacaftor-deutivacaftor (VTD; Alyftrek) showed great potential for modifying the progression of disease in young children, according to the TIMBERLINE study. Assessing safety and tolerability...

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 10 September →